Hudson Bay Capital Management
NAUT icon

Hudson Bay Capital Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Hudson Bay Capital Management’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-29,594
Closed -$115K – 1568
2026
Q1 		$115K Buy
29,594
+10,532
+55% +$25.9K ﹤0.01% 1165
2025
Q4 		$37.2K Buy
+19,062
New +$31.3K ﹤0.01% 1103
2020
Q4 		– Sell
-100,000
Closed -$1.07M – 663
2020
Q3 		$1.07M Buy
+100,000
New +$1.07M 0.02% 415

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Hudson Bay Capital Management's NAUT Position: Q2 2026 in Review

Hudson Bay Capital Management sold out of Nautilus Biotechnolgy (NAUT) in Q2 2026, closing a stake of 29,594 shares — an estimated $115K sold.

Hudson Bay Capital Management first reported a position in NAUT in Q3 2020 and held it in 3 quarters. The position peaked at $1.07M in Q3 2020. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Hudson Bay Capital Management reported no remaining Nautilus Biotechnolgy position as of Q2 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 29,594 Nautilus Biotechnolgy shares in Q2 2026, an estimated $115K.
  • Hudson Bay Capital Management first reported a position in Nautilus Biotechnolgy in Q3 2020 and held it in 3 quarters.
  • Hudson Bay Capital Management's Nautilus Biotechnolgy position peaked at $1.07M in Q3 2020.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.